Analyst Price Targets — CLGN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 2, 2024 11:47 am | Swayampakula Ramakanth | H.C. Wainwright | $11.00 | $4.34 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Collplant Holdings Inc. (CLGN) |
| August 5, 2024 7:52 am | Jason Kolbert | EF Hutton | $14.00 | $4.65 | StreetInsider | EF Hutton Starts Collplant Holdings Inc. (CLGN) at Buy |
Latest News for CLGN
REHOVOT, Israel, Sept. 1, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd.
LightSolver is pioneering pure photonic computing, bringing a new computing architecture to the public markets to address the speed, energy and heat limitations of semiconductor-based computing LightSolver has developed the world's first Laser Processing Unit™ (LPU™), combining the advantages of classical and quantum computing in a compact platform that operates without cryogenic or other extreme conditions and is…
REHOVOT, Israel, June 30, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 7,647,061 of the Company's…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CLGN.
U.S. House Trading
No House trades found for CLGN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.